Navigation Links
Ezra Van Gelder Joins Microchip Biotechnologies as Executive Vice President R&D
Date:12/4/2008

DUBLIN, Calif., Dec. 4 /PRNewswire/ -- Microchip Biotechnologies, a private company developing the Apollo next-generation fluidics platform for Life Sciences, announced today that Ezra Van Gelder has joined its team as Executive Vice President of R&D.

Ezra Van Gelder brings Microchip Biotechnologies (MBI) extensive leadership experience in research and development from the life science, medical device and semiconductor equipment industries. Prior to joining MBI, Ezra Van Gelder headed instrument and reagent development for DNA and RNA sample preparation at Arcxis Biosciences. At Molecular Dynamics, Amersham and GE Healthcare, where he was VP of Development for the West Coast, he led development for DNA sequencing and cell analysis. In the semiconductor industry Ezra Van Gelder directed the development of automated optical wafer inspection equipment at KLA Instruments and KLA-Tencor.

"The addition of Ezra Van Gelder, as Executive VP of R&D, further strengthens the world class team at MBI. Ezra brings considerable expertise in developing innovative next generation life science solutions focused on end users and implementing product development processes and ISO 13485," said Dr. Stevan Jovanovich, President and CEO of Microchip Biotechnologies. "Ezra's R&D leadership and experience will accelerate the full integration of sample preparation and analysis on MBI's Apollo platform."

"I have spent much of my career working on separate reagent and analytical instrumentation systems, so I am now relishing the prospect of working with a platform that can genuinely integrate macro and microfluidics to provide much needed, complete sample-to-answer solutions," said Ezra Van Gelder. "The Apollo platform, along with the exceptional group at MBI, will bring new capabilities to life sciences, diagnostics and compact field portable devices for life science applications."

Ezra Van Gelder holds a B.Sc. in Mechanical Engineering from Tel Aviv University, Israel and a M.Sc. in Mechanical Engineering from Santa Clara University, California, USA.

About Microchip Biotechnologies

Microchip Biotechnologies, Inc., also known as MBI, is a privately-held company that is located in Dublin, California. The company is developing the Apollo next-generation fluidics platform for life sciences, applied sciences, and diagnostics markets. The Apollo platform integrates advanced microfluidic sample preparation, and analytical capabilities, to produce sample-to-answer performance for DNA sequencing, biodefense, DNA-based forensics and human identity (HID), and molecular diagnostics applications. The platform incorporates MBI's proprietary BeadStorm(TM) bead-based sample preparation devices and 'Microscale On-Chip Valve' (MOVe(TM)) valves, pumps, and routers on NanoPulse(TM) microchips. More details about the MBI, its technologies and products can be found at: www.microchipbiotech.com.


'/>"/>
SOURCE Microchip Biotechnologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Richard Greco Joins Mediware Board
2. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
3. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
4. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
5. Nick Childs Joins Grey New York as Director of Content Development
6. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
7. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
8. NASN Joins Partnership to Fight Chronic Disease
9. AstraZeneca Joins Local Walking Movement
10. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
11. Fund Manager Joins Board of GSI Securitization Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information ... National Institute for Health and Care Excellence (NICE) framework. The agreement ... Health Service (NHS) to search, order and purchase medical and healthcare-related content through ...
(Date:2/23/2017)... Henderson, Nevada (PRWEB) , ... February 23, 2017 , ... ... Eastern Avenue in Henderson, NV 89052. Dr. Mahon was named a 2017 Top Patient ... Local Doctors is an online directory that recognizes local physicians and dentists who ...
(Date:2/23/2017)... ... 23, 2017 , ... ERT, a global data and technology ... Research, a leading clinical development service provider, has selected ERT’s Trial Oversight suite ... in part to an array of circumstances including the use of multiple data ...
(Date:2/23/2017)... ... February 23, 2017 , ... Healthcare Research & Analytics® (HRA®) ... fight against cancer, has produced a seminal study that asked cancer survivors and ... findings in a webinar, Defining Compassionate Care Through the Voices of Patients and ...
(Date:2/23/2017)... ... ... perfect opportunity for the nation to come together to combine ... bracket – with its favorite fruit – apples! To celebrate ... lovers to join the “Apple Madness” bracket tournament – a ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device company ... the urology market, will release financial results for the ... before the market open on Thursday, March 9, 2017. ... call and webcast to discuss its financial results the ... a.m. Eastern Time (10:00 a.m. Central Time). Darin ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
(Date:2/23/2017)... According to a new market ... Digital, Analog), MRI (Closed, Open), Ultrasound, CT, Nuclear Imaging ... User (Hospitals, Imaging Centers) - Global Forecast to 2021", ... over the forecast period of 2016 to 2021. The ... 2021, at a CAGR of 6.6% from 2016 to ...
Breaking Medicine Technology: